What innovative pricing model did Feng Zhang and the Broad Institute primarily use for their CRISPR-Cas9 patents that helped accelerate scientific research while maintaining commercial value?

Gene editing technology has transformed biomedical research, but how these innovations reach the market involves complex pricing strategies. The CRISPR-Cas9 gene editing system represents one of the most significant scientific breakthroughs of the 21st century, but its path to commercialization raised important questions about how transformative technologies should be priced and accessed. Test your knowledge about this fascinating intersection of cutting-edge science and pricing strategy!

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Dual-licensing: free academic use with commercial licensing fees
Premium subscription model with tiered access to different CRISPR variants
Pay-per-edit pricing where researchers are charged for each successful gene modification
Exclusive patent monopoly with uniform high licensing fees for all users